Immatics
在场
Immatics 是一家在股票代码 IMTX (DE) 下上市的公司。
Immatics 在 2 个国家有直接业务。
高管
查看带有其 50 名主要高管的组织结构图
Immatics 搜索最多的简介
- Harpreet Singh, Chief Executive Officer and Director
- Peter Chambré, Chairman of the Board
- Adam Stone, Director
高管在Immatics变化
- Alise Reicin已作为Director加入公司 (新闻发布的2024八月1号).
创建提醒
跟踪 Immatics 的高管变动
生物技术
Immatics 拥有 2,336 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AusperBio 刚刚宣布为 73 筹款数百万美元。 (公布2025一月3号).
- Visus Therapeutics and Tenpoint Therapeutics have merged (公布2024十二月27号)..
- Deerfield has announced the acquisition of Singular Genomics (公布2024十二月24号).
生物技术 行业的其他推荐联系人
消息
Immatics 的最新新闻稿
- Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer | Immatics N.V.
- Immatics Announces First Quarter 2022 Financial Results and Business Update | Immatics N.V.
- Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs | Immatics N.V.
- Immatics Announces First Patient Treated with ACTengine® IMA203 TCR-T in Combination with Checkpoint Inhibitor Opdivo® (nivolumab) in Patients with Advanced Solid Tumors | Immatics N.V.
- Immatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumors | Immatics N.V.
- German Press Releases | Immatics N.V.
- Immatics Announces Full Year 2021 Financial Results and Corporate Update | Immatics N.V.
- Press Releases | Immatics N.V.
- Immatics Appoints Cedrik Britten as Chief Medical Officer - Immatics
- Immatics Appoints Thomas Ulmer as Chief Financial Officer - Immatics
- View more press releases Close
关于 Immatics 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Harpreet Singh 
